The global biopharmaceutical sector brought in more than $15 billion to its collective coffers in the second quarter of the year, adding to the almost $23 billion it raised in the first quarter. According to BioWorld data, the $38 billion generated in the first half of the year overshadowed the $18.79 billion raised in the same period last year. The 2018 total now represents a significant record for the amount of cash that has been invested into the industry during a six-month period, beating by a wide margin the previous record established in 2015 when $27.2 billion was raised.